| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 234 | 1,059,753 | SCHB, SCHF, FNDX, FNDF | 13F-HR | 2/2/2024 | 000154216624000003 |
| Q3 2023 | 204 | 933,916 | SCHB, SCHF, FNDX, FNDF | 13F-HR | 11/6/2023 | 000154216623000013 |
| Q2 2023 | 183 | 904,077 | SCHB, SCHF, FNDF, FNDX | 13F-HR | 8/4/2023 | 000154216623000011 |
| Q1 2023 | 184 | 863,797 | SCHB, SCHF, FNDF, GSIE | RESTATEMENT | 6/13/2023 | 000154216623000009 |
| Q4 2022 | 186 | 809,650 | SCHB, SCHF, FNDF, GSIE | RESTATEMENT | 6/13/2023 | 000154216623000007 |
| Q3 2022 | 129 | 614,229 | SCHB, SCHF, FNDF, PRF | 13F-HR | 11/14/2022 | 000154216622000011 |
| Q2 2022 | 112 | 648,379 | SCHB, SCHF, FNDF, PRF | 13F-HR | 8/15/2022 | 000154216622000009 |
| Q1 2022 | 122 | 727,847 | SCHB, SCHF, FNDX, FNDF | 13F-HR | 5/10/2022 | 000154216622000004 |
| Q4 2021 | 133 | 688,032 | SCHB, SCHF, GSLC, PRF | 13F-HR | 1/21/2022 | 000154216622000002 |
| Q3 2021 | 87 | 601,512 | SCHB, SCHF, GSLC, PRF | 13F-HR | 10/14/2021 | 000154216621000009 |
| Q2 2021 | 89 | 575,330 | SCHB, SCHF, GSLC, PRF | 13F-HR | 8/10/2021 | 000154216621000007 |
| Q1 2021 | 86 | 549,847 | SCHB, SCHF, GSLC, PRF | 13F-HR | 5/10/2021 | 000154216621000005 |
| Q4 2020 | 83 | 491,590 | SCHB, SCHF, GSLC, PRF | 13F-HR | 2/2/2021 | 000154216621000003 |
| Q3 2020 | 78 | 445,541 | SCHB, GSLC, SCHF, PRF | 13F-HR | 10/23/2020 | 000154216620000008 |
| Q2 2020 | 86 | 398,819 | SCHB, SCHF, PRF, GSLC | 13F-HR | 8/4/2020 | 000154216620000006 |
| Q1 2020 | 81 | 324,804 | PRF, VEU, GSIE, SCHF | 13F-HR | 5/8/2020 | 000154216620000004 |
| Q4 2019 | 56 | 363,845 | PRF, VEU, IWB, GSIE | 13F-HR | 2/14/2020 | 000154216620000002 |
| Q3 2019 | 53 | 349,113 | PRF, VEU, IWB, GSIE | 13F-HR | 11/14/2019 | 000154216619000008 |
| Q2 2019 | 54 | 310,562 | PRF, VEU, MLPX, VXUS | 13F-HR | 8/12/2019 | 000154216619000006 |
| Q1 2019 | 53 | 306,329 | PRF, VEU, MLPX, VXUS | 13F-HR | 5/14/2019 | 000154216619000004 |
| Q4 2018 | 52 | 274,468 | PRF, VEU, VXUS, MLPX | 13F-HR | 2/14/2019 | 000154216619000002 |
| Q3 2018 | 50 | 302,926 | PRF, VEU, MLPX, GSLC | 13F-HR | 11/13/2018 | 000154216618000008 |
| Q2 2018 | 49 | 288,564 | PRF, VEU, MLPX, GSLC | 13F-HR | 8/10/2018 | 000154216618000006 |
| Q1 2018 | 51 | 308,813 | PRF, VEU, SHM, GSLC | 13F-HR | 5/4/2018 | 000154216618000004 |
| Q4 2017 | 51 | 287,206 | PRF, VEU, GSLC, XLK | 13F-HR | 2/13/2018 | 000154216618000002 |
| Q3 2017 | 50 | 268,100 | VEU, PRF, GSLC, XLK | 13F-HR | 11/8/2017 | 000154216617000008 |
| Q2 2017 | 51 | 264,418 | VEU, PRF, GSLC, XLK | 13F-HR | 8/8/2017 | 000154216617000006 |
| Q1 2017 | 49 | 250,543 | PRF, VEU, GSLC, XLK | 13F-HR | 5/10/2017 | 000154216617000004 |
| Q4 2016 | 37 | 222,200 | PRF, VEU, GSLC, XLK | 13F-HR | 2/9/2017 | 000154216617000002 |
| Q3 2016 | 44 | 242,840 | PRF, VEU, IBRX, GSLC | 13F-HR | 11/15/2016 | 000154216616000019 |
| Q2 2016 | 68 | 244,945 | PRF, VEU, IBRX, GSLC | 13F-HR | 8/12/2016 | 000154216616000017 |
| Q1 2016 | 63 | 238,523 | PRF, VEU, IBRX, GSLC | 13F-HR | 5/11/2016 | 000154216616000015 |
| Q4 2015 | 64 | 252,784 | IBRX, PRF, VEU, XLK | 13F-HR | 2/12/2016 | 000154216616000011 |
| Q3 2015 | 62 | 184,261 | IBRX, PRF, XLK, VCSH | 13F-HR | 11/10/2015 | 000154216615000009 |
| Q2 2015 | 70 | 476,503 | RCPT, PRF, SDY, VGK | 13F-HR | 8/13/2015 | 000154216615000007 |
| Q1 2015 | 68 | 470,081 | RCPT, SDY, PRF, VGK | 13F-HR | 5/11/2015 | 000154216615000005 |
| Q4 2014 | 72 | 440,754 | RCPT, SDY, PRF, Sorrento Therapeutics | 13F-HR | 2/10/2015 | 000154216615000003 |
| Q3 2014 | 65 | 361,444 | RCPT, SDY, PRF, VGK | 13F-HR | 11/12/2014 | 000154216614000012 |
| Q2 2014 | 74 | 373,917 | SDY, RCPT, PRF, VGK | 13F-HR | 8/13/2014 | 000154216614000009 |
| Q1 2014 | 55 | 299,592 | SDY, PRF, VGK, RCPT | 13F-HR | 5/8/2014 | 000154216614000005 |
| Q4 2013 | 54 | 261,643 | SDY, PRF, VGK, AMLP | RESTATEMENT | 2/13/2014 | 000154216614000003 |